Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.
Rossi SH, Newsham I, Pita S, Brennan K, Park G, Smith CG, Lach RP, Mitchell T, Huang J, Babbage A, Warren AY, Leppert JT, Stewart GD, Gevaert O, Massie CE, Samarajiwa SA.
Rossi SH, et al. Among authors: brennan k.
Sci Adv. 2022 Sep 30;8(39):eabn9828. doi: 10.1126/sciadv.abn9828. Epub 2022 Sep 28.
Sci Adv. 2022.
PMID: 36170366
Free PMC article.